Explore evidence

13.1 %HPV vaccination uptake among adolescents girls living with HIV (AGLHIV) in Côte d'Ivoire was 13.1% for those who had never attended a focus group on sexual education and 16.5% for those who had attended such a focus group in the COVADOCY study conducted in 2025.

Côte d'Ivoireinfection à HPVobserved 2025HAL · Unilimdocument of 69 observations

24 %Among hospitalized HIV-positive adults in West Africa, 24% discovered their HIV infection during the hospitalization.

Côte d'IvoireVIH/sidaobserved 2010published 2014Journal of the International AIDS Societyeurope_pmcdocument of 22 observationsDOI 10.7448/ias.17.1.18797

6,900 net_DALYs_per_yearThe resistance test policy led to 6900 fewer net DALYs per year compared with the switch policy.

Côte d'IvoireVIH/sidapublished 2025The lancet. HIVeurope_pmcdocument of 6 observations

1.29 per_100_person_monthsDuring the pre-intervention period, the incidence rates were 1.29 cases per 100 person-months in the LLIN plus Bti group.

Côte d'IvoirepaludismeHAL · Unilimdocument of 54 observations

5.4 log10_copies_per_mlThe median baseline HIV-1 RNA was 5.4 log10 copies/ml.

Côte d'IvoireVIH/sidapublished 2023AIDS (London, England)europe_pmcdocument of 6 observations

6.1 %HIV incidence among female sex workers who had 7 clients or more on the last day of work in Côte d'Ivoire was 6.1%.

Côte d'IvoireVIH/sidaobserved 2016-2017published 2022PloS oneeurope_pmcdocument of 10 observationsDOI 10.1371/journal.pone.0271988

No external and visible congenital malformation was observed in HIV-infected women exposed to nevirapine during pregnancy.

Côte d'IvoireVIH/sidaobserved 2003–2009published 2011Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 9 observationsDOI 10.1097/qai.0b013e3181ff04e6

6.04 log_10_copies_per_mLAt ARV-initiation, median HBV-DNA was 6.04 log 10 copies/mL in 86 antiretroviral-naïve HIV-HBV co-infected patients from Côte d'Ivoire.

Côte d'Ivoirehépatite Bpublished 2018Journal of viral hepatitiseurope_pmcdocument of 7 observationsDOI 10.1111/jvh.12914

1.24 %Mixed infection of Plasmodium falciparum and Plasmodium malariae accounted for 1.24% of 2246 identified Plasmodium species.

Côte d'IvoirePlasmodium falciparum + Plasmodium malariaeHAL · Unilimdocument of 122 observations

53 %Of the 19 isolated TB strains from inmates at the Correctional and Detention Facility of Abidjan, 10 (53%) were TB drug resistant.

Côte d'Ivoiretuberculoseobserved 2015published 2017PloS oneeurope_pmcdocument of 8 observations

12 %At month 12 after ART initiation, 12% of patients in active follow-up had virus resistant to at least one antiretroviral drug.

Côte d'IvoireVIH/sidapublished 2013Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 11 observations

462 per_mm3At baseline, the median CD4 count was 462/mm³ [IQR 368–571] in HIV-infected adults in the Temprano trial.

Côte d'IvoireVIH/sidapublished 2020EBioMedicineeurope_pmcdocument of 7 observations

10,000 copies/mLChronic HBeAg-negative HBV hepatitis phase was defined as HBV DNA >10,000 copies/mL and/or above normal ALT.

Côte d'Ivoirehépatite Bpublished 2019Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument of 4 observations

63 %Among hospitalized HIV-positive adults in West Africa who died, the underlying cause of death was AIDS in 63% of cases.

Côte d'IvoireVIH/sidaobserved 2010published 2014Journal of the International AIDS Societyeurope_pmcdocument of 22 observationsDOI 10.7448/ias.17.1.18797

64.9 %The 60-month survival rate among ART-experienced HIV-2 patients with drug-resistant viruses was 64.9%.

Côte d'IvoireVIH/sidapublished 2020PloS oneeurope_pmcdocument of 13 observationsDOI 10.1371/journal.pone.0236642

1.6 %In the TEMPRANO trial, 1.6% of adults considered free of active TB based on clinical screening at pre-inclusion actually had active TB.

Côte d'Ivoireactive TBpublished 2017The international journal of tuberculosis and lung disease : the official journal of the Ieurope_pmcdocument of 3 observations

14.9 %Among HBsAg-positive individuals, 14.9% were also positive for anti-HDV antibody.

Côte d'Ivoirehépatite B · hepatitis Delta virusobserved 2012published 2017BMC infectious diseaseseurope_pmcdocument of 7 observations

11 %HIV prevalence among first-time female blood donors in Abidjan decreased from 11.0% in 1992–1994 to 2.0% in 2010–2012.

Côte d'IvoireVIH/sidaobserved 1992–1994published 2018Open forum infectious diseaseseurope_pmcdocument of 12 observations

3,016 copies/mlMedian plasma HIV-2 RNA among patients with viral load more than 50 copies/ml was 3016 copies/ml.

Côte d'IvoireVIH/sidapublished 2014AIDS (London, England)europe_pmcdocument of 9 observations

48 %In the West and Central African region, 48% of people living with HIV are aware of their HIV status.

Côte d'IvoireVIH/sidapublished 2020International journal of infectious diseases : IJID : official publication of the Internateurope_pmcdocument of 3 observations

69 %The majority of patients (69%) were under antiretroviral treatment.

Côte d'IvoireVIH/sidaobserved January 2005-July 2015published 2018The Pan African medical journaleurope_pmcdocument of 9 observations

0.25 per_100_person_weeksThe mean weekly malaria incidence throughout the year in the overall population was 0.25 cases per 100 person-weeks.

Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations

13.4 %The prevalence of malaria cases detected by RDTs was 13.4% in Survey 3.

Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations

54 %At month 24 after ART initiation, 54% of patients with detectable viral loads had resistant virus.

Côte d'IvoireVIH/sidapublished 2013Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 11 observations

93 %A protease inhibitor was included in the antiretroviral chemoprophylaxis regimen in 93% of the cases.

Côte d'IvoireVIH/sidaobserved 2000-2007published 2010Medecine et maladies infectieuseseurope_pmcdocument of 13 observations